Urologix

Devices & Diagnostics

Massachusetts-based device company raises $34.76 million to fund US pivotal clinical trial, execute commercial strategy abroad

  GI Dynamics, Inc., a Lexington, Mass.-based company known for its EndoBarrier  Therapy, which it claims can reduce blood-sugar levels and offer weight-loss results in Type 2 Diabetes patients, has raised $34,755,000 in equity and CDIs, according to a regulatory filing it made with the SEC on July 22. The company still seeks $17,745,000, which […]

News

Urologix’s fiscal third-quarter loss widens

Urologix, which makes products to treat enlarged prostate, or benign prostatic hyperplasia, reported that its fiscal third-quarter revenue fell 17 percent because of “reduced order volume in direct, mobile and third-party mobile distribution channels.” The Plymouth, Minnesota-based company said that revenue was $2.98 million, down from $3.59 million a year ago. The loss widened to […]

Devices & Diagnostics

Urologix blames turnover, economy, reimbursement confusion for Q2 loss

The Plymouth-based company develops devices for treating enlarged prostate, or benign prostatic hyperplasia. Its Targis System uses microwave energy to heat and destroy enlarged prostate tissue as an alternative to pharmaceutical treatment. "The second quarter's results are disappointing and inconsistent with the efforts towards sustained, sequential revenue growth," CEO Stryker Warren Jr. said during the company's conference call.

Devices & Diagnostics

Urologix hires new finance chief

Urologix Inc. (Nasdaq: ULGX) has hired a new chief financial officer who previously worked as a controller for device firm Angeion Corp. Brian Smrdel takes over the CFO role from Rebecca Weber, who will stay on as Urologix’s director of finance, according to a statement from the Minneapolis-based company. “In addition to his accounting experience […]